Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma

Area of Science:

• Gynecologic Pathology
• Surgical Pathology
• Oncology

Background:

• Endometrial sarcomas are rare uterine malignancies.
• Distinguishing between subtypes is crucial for accurate diagnosis and prognosis.

Purpose of the Study:

• To review and classify endometrial sarcoma cases.
• To identify distinct clinicopathologic features and prognostic factors for endometrial stromal sarcoma and poorly differentiated endometrial sarcoma.

Main Methods:

• Retrospective review of U.T.M.D. Anderson Hospital cases filed as endometrial sarcoma.
• Exclusion of malignant mixed Müllerian tumors, Müllerian adenosarcomas, and sarcomas of uncertain origin.
• Pathologic examination and minimum 36-month follow-up for distinct group classification.

Main Results:

• Two distinct groups identified: endometrial stromal sarcoma (11 cases) and poorly differentiated endometrial sarcoma (7 cases).
• Endometrial stromal sarcoma showed uniform cells, distinctive vasculature, younger patients (<50 yrs), and better prognosis (8/11 tumor-free).
• Poorly differentiated endometrial sarcoma had larger, pleomorphic cells, older patients (>50 yrs), and poorer prognosis (6/7 died of tumor).
• Tumor extent (extrauterine spread or myometrial invasion) was the major prognostic factor for both types.

Conclusions:

• Endometrial stromal sarcoma is a distinct entity, and diagnosis should not rely solely on mitotic rate.
• Poorly differentiated endometrial sarcoma may be closely related to malignant mixed Müllerian tumors.
• Tumor stage is the most significant prognostic indicator for both endometrial sarcoma subtypes.